The two genes mutated in the bone marrow failure syndrome dyskeratosis congenita (DC) both encode components of the telomerase complex, responsible for maintaining the ends of chromosomes in stem cells and in the germ line. In reviewing the mutation profile that is found in DC we describe 9 novel mutations in the DKC1 gene and 3 novel TERC mutations, responsible for the X-linked and autosomal dominant forms of the disease respectively, but find that two thirds of the families do not have mutations in either of these genes. In a significant subset of these uncharacterised families, the index case presents with severe disease previously defined as the Hoyeraal-Hreidarsson (HH) syndrome. The diverse clinical phenotype seen in patients with X-linked DC is not explained by the different amino acid substitutions: presentation of the recurrent A353V substitution ranges from classical DC to the severe HH variant. However, we do see that patients with HH have significantly shorter telomeres than those with a relatively mild presentation. In the new families described with TERC mutations, there is further evidence of disease anticipation associated with shorter telomeres in the younger generations. This study highlights the considerable genetic and phenotypic diversity of DC.
Introduction
Dyskeratosis congenita (DC) is a bone marrow failure syndrome, classically associated with a triad of mucocutaneous features: nail dystrophy, oral leukoplakia and abnormal reticulate skin pigmentation. 1 In contrast to Fanconi anemia, in which a diagnosis can be made on the basis ribosomal RNA. 21 However, mouse ES cells that harbour missense mutations in Dkc1 show defects in both telomerase and pseudouridylation. 22 Several interesting questions therefore remain. We do not know to what extent the defect in ribosome biogenesis is important in the development of X-linked DC. The precise mechanism whereby missense mutations in a TERC-associated protein and heterozygous mutations in TERC itself lead to remarkably similar phenotypes remains to be determined. It has been
shown that disease anticipation in families with autosomal dominant DC is associated with telomere shortening, 7 but we do not know whether telomere length has anything to do with the severity of the disease in X-linked families. We are also interested to determine whether any of the other members of these ribonucleoprotein complexes are involved in DC, including the reverse transcriptase component of telomerase (TERT), which has recently been shown to be mutated in a small proportion of patients with aplastic anemia.
23,24
In order to try and answer some of these questions we can refer to the DC registry at the Hammersmith Hospital in London that now represents more than 228 families. In this paper we review the mutations that have been identified in these families, assess genotypephenotype correlations, and investigate whether there is any relationship between telomere length and severity of DC.
Subjects and methods
The DC Registry (DCR) . Families are recruited to the DCR from all over the world. We currently have clinical and genetic information for 228 families registered from 40 different countries, comprising 354 affected individuals. The criteria for admission to the DCR have changed over the years. Initially, families were included only when the index case presented with the triad of diagnostic mucocutaneous features (nail dystrophy, leukoplakia and abnormal skin pigmentation). As it became clear that not all DC patients have all of these features, we have extended recruitment to include families in which the index case has one or more of these mucocutaneous features, combined with a hypoplastic bone marrow and at least two of the other somatic features known to occur in DC. 3 Patients are also entered into the DCR if they have at least 4 out of 6 of the most commonly recognised features of HH: these are inter- Mutation screening. In families with only affected males, the entire coding sequence and 5' flanking sequence of the DKC1 gene is screened for point mutation by denaturing high performance liquid chromatography (HPLC) analysis on a WAVE DNA fragment analysis system (Transgenomic, Paris). The gene is amplified in 15 different fragments using the PCR conditions and primer pairs previously described. 25 After mixing with amplified wild type DNA, these fragments are denatured and slowly cooled to allow for heteroduplex formation prior to screening at two different temperatures selected using the Wavemaker software (Transgenomic). When abnormal elution patterns are detected, the appropriate fragments are re-amplified and subjected to direct sequence analysis by BigDye TM chain termination cycle sequencing and fragment analysis on the 3700 DNA analyser (Applied Biosystems Inc.). Any mutations identified are confirmed either by sequencing of the reverse strand or by reamplification and restriction enzyme digestion, using sites that are created or destroyed by the mutation. All families are also screened for mutation in the TERC gene by both Southern blot and denaturing HPLC analysis using the probe, primer pair and PCR conditions previously described. 13 Screening of the gene encoding TERT was performed by denaturing HPLC and direct DNA sequence analysis as previously described.
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Telomere length measurement. Telomere length was measured by Southern blot analysis using a sub-telomeric probe from chromosome 7 (pTelBam8) as described elsewhere. 26 The size of the peak of the signal intensity was determined using the Gel Blot Pro software (UVP).
Unaffected sibs and spouses in families in which DKC1 or TERC mutations have been identified were used as age-matched normal controls. In order to adjust telomere length measurement for age, a linear regression line was calculated for telomere length against age in these 100 normal individuals. The telomere length of affected individuals was then expressed as the difference between the observed length and the age-adjusted normal telomere length predicted from the linear regression line (deltaTEL).
27

Results
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Inheritance patterns in DC. Although DC is thought of primarily as an X-linked recessive disorder, of 228 families entered in to the DC registry (DCR), only 22 of them show true Xlinked inheritance, with affected maternal uncles or male cousins of the index case. In 19 families there are at least two affected brothers, but in the majority of families (123) the affected male is a sporadic case. In the remaining 64 families there is one or more affected female. Again, in the majority of these (35) there is only one sporadic female case while 18 families show autosomal recessive inheritance and 11 show autosomal dominant inheritance (Table 1) . (Table 1 ). It is noteworthy that amongst the HH families with affected males the proportions of the different types of families (X-linked, two affected male sibs and sporadic males) that have DKC1 mutations is broadly similar to that seen in DC as a whole (see Table 1 ).
Mutations in X-
As previously noted, these mutations almost always cause amino acid substitutions, which appear to cluster in two distinct regions of the dyskerin protein ( Figure 2 ). Most of these mutations are unique although four have been seen twice, one has been seen four times and one (A353V) has been seen thirty times (see below). Those that have not been described previously are listed in Table 2 . One mutation presented here that is an exception to the rule is the A->G substitution occurring at the AG acceptor splice site of the last intron of the gene.
RNA is not available from this case, and so we cannot establish what this mutation does to the 3' end of the DKC1 transcript. However it may be relevant that another DC case has a 2kb deletion that removes the 3' end of this intron as well as the final exon of DKC1.
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There does not seem to be any clear correlation between the location of the dyskerin mutation and the severity of the disease: mutations that cause the most severe form of DC, previously recognised as the Hoyeraal Hreidarsson (HH) syndrome, are located in both mutation clusters, although 2 of these amino acid substitutions (S121G and R158W) do not fall into either cluster. Of the 48 families in which the index case presents with, or has features of HH, 32 are male and 15 of them have eight different DKC1 mutations (underlined in Figure   2 ). One of these (T49M) has been seen in 4 different families, and is only seen in HH patients, indicating that there is a consistent phenotype for this amino acid substitution.
However, 4 other families with HH have the commonly recurring A353V mutation (see below).
In the 16 HH families in which there is an affected female, none have DKC1 mutations, 7 are sporadic, 9 appear to have an autosomal recessive form and none appear to have an autosomal dominant form of the disease. These observations highlight the existence of a significant fraction of autosomal (non DKC1) HH, the genetic basis of which presently remains unknown.
Phenotypic diversity in patients with A353V. Remarkably, 30 out of the 72 DC families in the DCR that have DKC1 mutations have the same mutation (1058 C->T) causing an A353V substitution, representing ~42% of X-linked DC. These families are unrelated, and in 12 of them the mutation has occurred de novo. In order to investigate the relationship between genotype and phenotype in this group of patients we have stratified the severity of the disease into four categories: (1) those that presented at the age of 15 years or more, have DC but do not have aplastic anemia (AA) -defined as a cytopenia of 2 or more lineages (Hb <8 g/dl, neutrophils <0.5 x10 9 /l and/or platelets <100 x10 9 /l); (2) information on both of these aspects. As above, the patients are divided into four clinical categories based on age of presentation (categories 1 and 2), the presence of AA (category 3) and the presence of HH (category 4). Telomere lengths are corrected for age by subtracting the predicted telomere length (obtained from a line of best fit drawn through a plot of telomere length against age for 100 normal subjects) from the observed telomere length to obtain a deltaTEL measurement, as described elsewhere. 27 The results of this analysis are shown in Figure 3 and Table 4 Table 5 . Unlike other natural mutations that have been described in TERC, two of these are located in the template region of the molecule (Figure 4) .
Two of these new mutations were identified in males without a family history, one of whom had bone marrow failure and nail dystrophy at the age of 16, while the other was a 13 year old with hypoplastic myelodysplasia and nail dystrophy. The third new mutation was identified in a family in which two men presented with AA/pancytopenia in their 40's, one of whom had 7 In two of the families, an asymptomatic parent has been shown to carry the TERC mutation, confirming that these are constitutional. In both cases, the age-adjusted telomere length (deltaTEL) of the affected children is shorter than that seen in the asymptomatic affected parent (child deltaTEl -parent deltaTEl = -2.9 and -2.16).
TERT mutations in the DCR. We have previously reported on the screening of the TERT gene in 24 families from the DCR.
24 Among these we identified one heterozygous missense mutation in a girl with HH in a family with apparent autosomal recessive inheritance of the disease. Her asymptomatic mother was also heterozygous for the mutation. It has been shown elsewhere that heterozygous TERT mutations can impair telomerase activity by haploinsufficiency and that they may be risk factors for marrow failure. 23 We have now screened an additional 50 patients from the DCR from families with autosomal dominant and recessive inheritance as well as sporadic affected males and females (Table 6 ).
In this group of patients we have identified 8 novel sequence changes, including one that causes a missense mutation (Table 6 ), in addition to 5 other previously described synonymous and intronic mutations. The P721R substitution, that is predicted to result from the novel 2162 C->G missense mutation, lies in Motif A of the RT domain of TERT. 30 It was identified in a two-year-old girl with DC in a family of consanguineous marriage and apparent autosomal recessive inheritance of the disease. She is heterozygous for this mutation, as are her older asymptomatic sister and her asymptomatic mother. Two maternal aunts and one first cousin who have nail dystrophy are also heterozygous for this mutation. It was not detected amongst 95 ethnically matched normal individuals.
Discussion
Recent interest in the bone marrow failure syndrome DC has largely focussed on the fact that some families with this disease have mutations in the gene encoding the RNA component of telomerase. 13 However, the most widely recognised form of this disease is caused by mutations in dyskerin, a protein that is involved both in the telomerase complex 12 as well as the H/ACA small nucleolar ribonucleoprotien complex that is responsible for the site-specific modification of uracil residues during ribosomal RNA processing. [9] [10] [11] In this paper we have
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From reviewed the mutation profile among 228 DC families that have been referred to the DC registry at the Hammersmith Hospital in London and describe eight novel missense mutations and one splicing mutation in the DKC1 gene as well as three novel mutations in the TERC gene. However, one of the most striking findings of this survey is the large proportion of DC families (144/228, 63%) in which we have not found a mutation in either of these genes.
Although a small proportion of mutations might have been be missed by the denaturing HPLC screen, we can infer that one or a few DC genes are still to be discovered. In a significant subset of these uncharacterised families (33/144) the index case has features of the severe variant HH.
Obvious candidates for mutation in these uncharacterised families are the other protein components that are found in both telomerase and the small nucleolar ribonucleoprotien complex, namely GAR1, NHP2 and NOP10. Previous work has shown that these are not commonly mutated in autosomal recessive DC, and the gene(s) responsible for this sub-type of DC remain unknown. 31 Of the 18 families that show autosomal recessive inheritance of DC, 10 involve a consanguineous marriage where it is likely that one pathogenic mutation is present in the homozygous state.
Recently it has been shown that a small proportion of patients with familial aplastic anemia and DC have heterozygous mutations in the gene that encodes the reverse transcriptase component of telomerase (TERT). 23, 24 Although some of these mutations have been shown to result in reduced telomerase activity in vitro, they do not appear to segregate with the disease in the few families described. The novel missense mutation described here seems to fit this pattern. So while it appears that they may act as risk factors for bone marrow failure, their direct pathogenic role remains to be established. What is clear is that TERT mutations do not account for a significant proportion of the uncharacterised DC families.
Relatively little is known about the functional consequences of the many missense mutations that have been described in dyskerin. This is partly due to the fact that any subtle effects that these may have are difficult to assay, although an artificial mutation in the catalytic centre has been shown, in other species, to abolish pseudouridylation activity and significantly reduce H/ACA RNA association. 32, 33 On the other hand, in one patient with a Q31E substitution, a reduction in the level of telomerase RNA in peripheral blood has been demonstrated. 34 However, it is clear that there is quite a substantial variation in the levels of telomerase
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From activity seen in normal blood samples and this does not seem to be significantly different in patients with DKC1 mutations. 29 The 3D structure of dyskerin has not been elucidated and functional domains of the protein can only be inferred through reference to orthologues in other species (see Figure 2) . It can be seen that several mutations fall in the PUA domain, conserved in pseudouridylases and archaeosine transglycosylases. Only 2 amino acid substitutions fall in the TruB domain, in which the catalytic 125Asp residue lies, but there is a significant cluster near the N-terminal of the protein, the function of which is unknown. It is possible that some of these simply cause the protein to be unstable.
There does not seem to be any clear relationship between the location of the amino acid substitution and the severity of the disease, although two missense mutations (I38T and T49M) have now been seen to be repeatedly associated with a severe clinical phenotype, previously characterised as the Hoyeraal Hreidarsson (HH) syndrome. The one amino acid substitution (A353V) that accounts for more than 40% of the families with DC due to dyskerin mutations, can cause a full spectrum of disease severity, indicating that other genetic or environmental factors are clearly important in the disease phenotype.
One thing that is clear is that patients with DC have significantly shorter telomeres than agematched controls. 14, 29 We have also shown here that among the patients with DKC1
mutations, those with the most severe form of DC have significantly shorter telomeres than those with a milder form of the disease. This is consistent with the idea that a defective dyskerin results in impaired telomerase activity, leading to shorter telomeres and premature ageing of the tissues that require constant turnover. These data, together with the disease anticipation (increasing disease severity with succeeding generations) associated with progressive telomere shortening observed in AD DC families 7 and Terc -/-mice 19 , also suggest that the shortest telomeres cause the most severe disease. Further evidence in support of this observation comes from the two families presented here with novel TERC mutations for which we have the appropriate clinical and genetic information: in both cases, the affected children have shorter age-adjusted telomere lengths than their asymptomatic affected parents. The clinical features observed in these families provide further support for the overlap of autosomal dominant DC with aplastic anemia observed previously.
35-37
Of the three TERC mutations described here, two are particularly interesting in that they are the first natural mutants to be described that disrupt the template region of the molecule which
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From is directly responsible for the synthesis of the telomeric repeat sequences. It will be interesting to investigate whether these mutations cause DC through haploinsufficiency, like those that have been described previously, [38] [39] [40] or whether they may have some dominant negative effect on the telomerase complex. substitution has previously been shown to be polymorphic; the F1127L substitution has also been described previously; the P721R substitution is described in this paper. (n) is the number of times each mutation has been observed in this series of 74 patients. c Previously published synonymous and intronic sequence changes are not included. ins = insertion. 
